ARTAX BIOPHARMA INC has a total of 35 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SPLICOS SOC, PHOENIX PHARMALABS INC and CUROVIR AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Spain | 2 | |
#8 | Brazil | 1 | |
#9 | Colombia | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Gagete Mateos Andrés | 16 |
#2 | Marti Clauzel Luc | 15 |
#3 | Castro Palomino Julio | 15 |
#4 | Vandeusen Christopher Loren | 10 |
#5 | Machin Peter J | 10 |
#6 | Castro Julio | 10 |
#7 | Gagete Mateos Andres | 9 |
#8 | Palomino Julio Castro | 8 |
#9 | Clauzel Luc Marti | 8 |
#10 | Tormo Carulla Damiá | 7 |
Publication | Filing date | Title |
---|---|---|
CA3091202A1 | Chromene derivatives as inhibitors of tcr-nck interaction | |
EP3375778A1 | Aryl-piperidine derivatives | |
EP3375784A1 | Aza-dihydro-acridone derivatives | |
ES2534336A1 | Chromene derivatives as inhibitors of the TCR-Nck interaction | |
ES2534318A1 | Alkoxide substituted chromene derivatives as inhibitors of the TCR-Nck interaction |